NYSE - Nasdaq Real Time Price USD

Albemarle Corporation (ALB)

Compare
87.26 -2.72 (-3.02%)
As of 1:11:29 PM EST. Market Open.
Loading Chart for ALB
DELL
  • Previous Close 89.98
  • Open 88.81
  • Bid 86.86 x 800
  • Ask 86.87 x 800
  • Day's Range 86.65 - 88.81
  • 52 Week Range 71.97 - 143.19
  • Volume 654,304
  • Avg. Volume 2,109,770
  • Market Cap (intraday) 10.257B
  • Beta (5Y Monthly) 1.55
  • PE Ratio (TTM) --
  • EPS (TTM) -16.76
  • Earnings Date Feb 12, 2025 - Feb 17, 2025
  • Forward Dividend & Yield 1.62 (1.80%)
  • Ex-Dividend Date Dec 13, 2024
  • 1y Target Est 117.72

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

www.albemarle.com

9,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALB

View More

Performance Overview: ALB

Trailing total returns as of 1/8/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALB
1.31%
S&P 500
0.03%

1-Year Return

ALB
34.76%
S&P 500
25.72%

3-Year Return

ALB
61.88%
S&P 500
26.26%

5-Year Return

ALB
27.35%
S&P 500
82.42%

Compare To: ALB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALB

View More

Valuation Measures

As of 1/7/2025
  • Market Cap

    10.58B

  • Enterprise Value

    14.72B

  • Trailing P/E

    35.46

  • Forward P/E

    81.97

  • PEG Ratio (5yr expected)

    8.04

  • Price/Sales (ttm)

    1.63

  • Price/Book (mrq)

    1.32

  • Enterprise Value/Revenue

    2.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.80%

  • Return on Assets (ttm)

    -5.18%

  • Return on Equity (ttm)

    -17.66%

  • Revenue (ttm)

    6.5B

  • Net Income Avi to Common (ttm)

    -1.97B

  • Diluted EPS (ttm)

    -16.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.66B

  • Total Debt/Equity (mrq)

    35.33%

  • Levered Free Cash Flow (ttm)

    -1.79B

Research Analysis: ALB

View More

People Also Watch